• Executive Summary
  • Glioblastoma
  • Management Team
  • Clinical Trials
  • CTO Overview
    • CTO Overview
    • Mechanism of Action
    • Preclinical Results
    • Intellectual Property
    • Pipeline
  • Publications
    • Abstracts
    • Articles
    • Press Releases
  • Contact
Next →

PLoS One, August 2012

  • August 27, 2016
  • admin
  • Uncategorized
  • 0 Comments

“Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis” Chiara Corrado, Anna Maria Flugy, Simona Taverna, Stefania Raimondo, Giuliana Guggino, Rashida Karmali, Giacomo De Leo, Riccardo Alessandro

Share

admin

jacob@burchtechnologies.com
0 Comments 0 Like

Copyright © 2016. Tactical Therapeutics, Inc. All Rights Reserved.